APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lisinopril

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lisinopril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchLisinopril Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisinopril Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Lisinopril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisinopril Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisinopril Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Lisinopril market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lisinopril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lisinopril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lisinopril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lisinopril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lisinopril include Teva Pharmaceuticals, Novartis, Mylan Pharmaceuticals, Astrazeneca, Wockhardt, West Ward Pharmaceutical, Watson Laboratories, Vintage Pharmaceuticals and SUN Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lisinopril market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lisinopril and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lisinopril sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lisinopril market size, projected growth trends, production technologies, key applications, and end-use industries.

Lisinopril Segment by Company

Teva Pharmaceuticals

Novartis

Mylan Pharmaceuticals

Astrazeneca

Wockhardt

West Ward Pharmaceutical

Watson Laboratories

Vintage Pharmaceuticals

SUN Pharm

Ranbaxy Pharmaceuticals

Prinston

Merck Research Laboratories

Lupin

Lek Pharmaceuticals

Ivax Pharmaceuticals

Invagen Pharms

Hikma

CASI Pharms

Aurobindo Pharma

Apotex

Alvogen

Actavis Elizabeth

Accord Hlthcare

Lisinopril Segment by Type

10mg

2.5mg

20mg

30mg

40mg

5mg

Lisinopril Segment by Application

Hospital

Drug Store

Lisinopril Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisinopril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisinopril and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisinopril.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lisinopril market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lisinopril manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lisinopril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lisinopril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lisinopril Industry Trends Table 2. Lisinopril Industry Drivers Table 3. Lisinopril Industry Opportunities and Challenges Table 4. Lisinopril Industry Restraints Table 5. Global Lisinopril Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lisinopril Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lisinopril Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lisinopril Sales Market Share by Manufacturers Table 9. Global Lisinopril Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lisinopril Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lisinopril Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lisinopril Manufacturers, Product Type & Application Table 13. Global Lisinopril Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lisinopril by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mg Table 17. Major Manufacturers of 2.5mg Table 18. Major Manufacturers of 20mg Table 19. Major Manufacturers of 30mg Table 20. Major Manufacturers of 40mg Table 21. Major Manufacturers of 5mg Table 22. Global Lisinopril Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Lisinopril Sales by Type (2021-2026) & (K Units) Table 24. Global Lisinopril Sales by Type (2027-2032) & (K Units) Table 25. Global Lisinopril Sales Market Share by Type (2021-2026) Table 26. Global Lisinopril Sales Market Share by Type (2027-2032) Table 27. Global Lisinopril Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Lisinopril Revenue by Type (2021-2026) & (K Units) Table 29. Global Lisinopril Revenue by Type (2027-2032) & (K Units) Table 30. Global Lisinopril Revenue Market Share by Type (2021-2026) Table 31. Global Lisinopril Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Drug Store Table 34. Global Lisinopril Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Lisinopril Sales by Application (2021-2026) & (K Units) Table 36. Global Lisinopril Sales by Application (2027-2032) & (K Units) Table 37. Global Lisinopril Sales Market Share by Application (2021-2026) Table 38. Global Lisinopril Sales Market Share by Application (2027-2032) Table 39. Global Lisinopril Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Lisinopril Revenue by Application (2021-2026) & (K Units) Table 41. Global Lisinopril Revenue by Application (2027-2032) & (K Units) Table 42. Global Lisinopril Revenue Market Share by Application (2021-2026) Table 43. Global Lisinopril Revenue Market Share by Application (2027-2032) Table 44. Global Lisinopril Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Lisinopril Sales by Region (2021-2026) & (K Units) Table 46. Global Lisinopril Sales Market Share by Region (2021-2026) Table 47. Global Lisinopril Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Lisinopril Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Lisinopril Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Lisinopril Sales by Country (2021-2026) & (K Units) Table 51. North America Lisinopril Sales by Country (2027-2032) & (K Units) Table 52. Europe Lisinopril Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Lisinopril Sales by Country (2021-2026) & (K Units) Table 54. Europe Lisinopril Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Lisinopril Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Lisinopril Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Lisinopril Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Lisinopril Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Lisinopril Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Lisinopril Sales by Country (2027-2032) & (K Units) Table 61. Global Lisinopril Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Lisinopril Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Lisinopril Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Lisinopril Revenue Market Share by Region (2021-2026) Table 65. Global Lisinopril Revenue Market Share by Region (2027-2032) Table 66. Teva Pharmaceuticals Company Information Table 67. Teva Pharmaceuticals Business Overview Table 68. Teva Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Teva Pharmaceuticals Lisinopril Product Portfolio Table 70. Teva Pharmaceuticals Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Novartis Lisinopril Product Portfolio Table 75. Novartis Recent Development Table 76. Mylan Pharmaceuticals Company Information Table 77. Mylan Pharmaceuticals Business Overview Table 78. Mylan Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Mylan Pharmaceuticals Lisinopril Product Portfolio Table 80. Mylan Pharmaceuticals Recent Development Table 81. Astrazeneca Company Information Table 82. Astrazeneca Business Overview Table 83. Astrazeneca Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Astrazeneca Lisinopril Product Portfolio Table 85. Astrazeneca Recent Development Table 86. Wockhardt Company Information Table 87. Wockhardt Business Overview Table 88. Wockhardt Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Wockhardt Lisinopril Product Portfolio Table 90. Wockhardt Recent Development Table 91. West Ward Pharmaceutical Company Information Table 92. West Ward Pharmaceutical Business Overview Table 93. West Ward Pharmaceutical Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. West Ward Pharmaceutical Lisinopril Product Portfolio Table 95. West Ward Pharmaceutical Recent Development Table 96. Watson Laboratories Company Information Table 97. Watson Laboratories Business Overview Table 98. Watson Laboratories Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Watson Laboratories Lisinopril Product Portfolio Table 100. Watson Laboratories Recent Development Table 101. Vintage Pharmaceuticals Company Information Table 102. Vintage Pharmaceuticals Business Overview Table 103. Vintage Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Vintage Pharmaceuticals Lisinopril Product Portfolio Table 105. Vintage Pharmaceuticals Recent Development Table 106. SUN Pharm Company Information Table 107. SUN Pharm Business Overview Table 108. SUN Pharm Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. SUN Pharm Lisinopril Product Portfolio Table 110. SUN Pharm Recent Development Table 111. Ranbaxy Pharmaceuticals Company Information Table 112. Ranbaxy Pharmaceuticals Business Overview Table 113. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Ranbaxy Pharmaceuticals Lisinopril Product Portfolio Table 115. Ranbaxy Pharmaceuticals Recent Development Table 116. Prinston Company Information Table 117. Prinston Business Overview Table 118. Prinston Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Prinston Lisinopril Product Portfolio Table 120. Prinston Recent Development Table 121. Merck Research Laboratories Company Information Table 122. Merck Research Laboratories Business Overview Table 123. Merck Research Laboratories Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Merck Research Laboratories Lisinopril Product Portfolio Table 125. Merck Research Laboratories Recent Development Table 126. Lupin Company Information Table 127. Lupin Business Overview Table 128. Lupin Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Lupin Lisinopril Product Portfolio Table 130. Lupin Recent Development Table 131. Lek Pharmaceuticals Company Information Table 132. Lek Pharmaceuticals Business Overview Table 133. Lek Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Lek Pharmaceuticals Lisinopril Product Portfolio Table 135. Lek Pharmaceuticals Recent Development Table 136. Ivax Pharmaceuticals Company Information Table 137. Ivax Pharmaceuticals Business Overview Table 138. Ivax Pharmaceuticals Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Ivax Pharmaceuticals Lisinopril Product Portfolio Table 140. Ivax Pharmaceuticals Recent Development Table 141. Invagen Pharms Company Information Table 142. Invagen Pharms Business Overview Table 143. Invagen Pharms Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Invagen Pharms Lisinopril Product Portfolio Table 145. Invagen Pharms Recent Development Table 146. Hikma Company Information Table 147. Hikma Business Overview Table 148. Hikma Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Hikma Lisinopril Product Portfolio Table 150. Hikma Recent Development Table 151. CASI Pharms Company Information Table 152. CASI Pharms Business Overview Table 153. CASI Pharms Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. CASI Pharms Lisinopril Product Portfolio Table 155. CASI Pharms Recent Development Table 156. Aurobindo Pharma Company Information Table 157. Aurobindo Pharma Business Overview Table 158. Aurobindo Pharma Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Aurobindo Pharma Lisinopril Product Portfolio Table 160. Aurobindo Pharma Recent Development Table 161. Apotex Company Information Table 162. Apotex Business Overview Table 163. Apotex Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Apotex Lisinopril Product Portfolio Table 165. Apotex Recent Development Table 166. Alvogen Company Information Table 167. Alvogen Business Overview Table 168. Alvogen Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Alvogen Lisinopril Product Portfolio Table 170. Alvogen Recent Development Table 171. Actavis Elizabeth Company Information Table 172. Actavis Elizabeth Business Overview Table 173. Actavis Elizabeth Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Actavis Elizabeth Lisinopril Product Portfolio Table 175. Actavis Elizabeth Recent Development Table 176. Accord Hlthcare Company Information Table 177. Accord Hlthcare Business Overview Table 178. Accord Hlthcare Lisinopril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. Accord Hlthcare Lisinopril Product Portfolio Table 180. Accord Hlthcare Recent Development Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Lisinopril Distributors List Table 184. Lisinopril Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Lisinopril Product Image Figure 2. Global Lisinopril Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lisinopril Market Size (2021-2032) & (US$ Million) Figure 4. Global Lisinopril Sales (2021-2032) & (K Units) Figure 5. Global Lisinopril Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lisinopril Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mg Image Figure 9. 2.5mg Image Figure 10. 20mg Image Figure 11. 30mg Image Figure 12. 40mg Image Figure 13. 5mg Image Figure 14. Global Lisinopril Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Lisinopril Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Lisinopril Sales Market Share by Type (2021-2032) Figure 17. Global Lisinopril Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Lisinopril Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Lisinopril Revenue Market Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Drug Store Image Figure 22. Global Lisinopril Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Lisinopril Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lisinopril Sales Market Share by Application (2021-2032) Figure 25. Global Lisinopril Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Lisinopril Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Lisinopril Revenue Market Share by Application (2021-2032) Figure 28. North America Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Lisinopril Sales Market Share by Country (2021-2032) Figure 30. U.S. Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Lisinopril Sales Market Share by Country (2021-2032) Figure 35. Germany Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Lisinopril Sales Market Share by Country (2021-2032) Figure 42. China Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Lisinopril Sales Market Share by Country (2021-2032) Figure 50. Brazil Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Lisinopril Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Lisinopril Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Lisinopril Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Lisinopril Revenue (2021-2032) & (US$ Million) Figure 61. North America Lisinopril Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Lisinopril Revenue (2021-2032) & (US$ Million) Figure 63. Europe Lisinopril Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Lisinopril Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Lisinopril Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Lisinopril Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Lisinopril Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Lisinopril Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Lisinopril Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 2.5mg
  • 20mg
  • 30mg
  • 40mg
  • 5mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva Pharmaceuticals
  • Novartis
  • Mylan Pharmaceuticals
  • Astrazeneca
  • Wockhardt
  • West Ward Pharmaceutical
  • Watson Laboratories
  • Vintage Pharmaceuticals
  • SUN Pharm
  • Ranbaxy Pharmaceuticals
  • Prinston
  • Merck Research Laboratories
  • Lupin
  • Lek Pharmaceuticals
  • Ivax Pharmaceuticals
  • Invagen Pharms
  • Hikma
  • CASI Pharms
  • Aurobindo Pharma
  • Apotex
  • Alvogen
  • Actavis Elizabeth
  • Accord Hlthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lisinopril Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lisinopril Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lisinopril Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lisinopril Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lisinopril Market Dynamics
  1. 2.1 Lisinopril Industry Trends
  2. 2.2 Lisinopril Industry Drivers
  3. 2.3 Lisinopril Industry Opportunities and Challenges
  4. 2.4 Lisinopril Industry Restraints
3 Lisinopril Market by Manufacturers
  1. 3.1 Global Lisinopril Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lisinopril Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lisinopril Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lisinopril Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lisinopril Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lisinopril Manufacturers, Product Type & Application
  7. 3.7 Global Lisinopril Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lisinopril Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lisinopril Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lisinopril Tier 1, Tier 2, and Tier 3
4 Lisinopril Market by Type
  1. 4.1 Lisinopril Type Introduction
  2. 4.1.1 10mg
  3. 4.1.2 2.5mg
  4. 4.1.3 20mg
  5. 4.1.4 30mg
  6. 4.1.5 40mg
  7. 4.1.6 5mg
  8. 4.2 Global Lisinopril Sales by Type
  9. 4.2.1 Global Lisinopril Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Lisinopril Sales by Type (2021-2032)
  11. 4.2.3 Global Lisinopril Sales Market Share by Type (2021-2032)
  12. 4.3 Global Lisinopril Revenue by Type
  13. 4.3.1 Global Lisinopril Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Lisinopril Revenue by Type (2021-2032)
  15. 4.3.3 Global Lisinopril Revenue Market Share by Type (2021-2032)
5 Lisinopril Market by Application
  1. 5.1 Lisinopril Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Lisinopril Sales by Application
  5. 5.2.1 Global Lisinopril Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Lisinopril Sales by Application (2021-2032)
  7. 5.2.3 Global Lisinopril Sales Market Share by Application (2021-2032)
  8. 5.3 Global Lisinopril Revenue by Application
  9. 5.3.1 Global Lisinopril Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Lisinopril Revenue by Application (2021-2032)
  11. 5.3.3 Global Lisinopril Revenue Market Share by Application (2021-2032)
6 Global Lisinopril Sales by Region
  1. 6.1 Global Lisinopril Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lisinopril Sales by Region (2021-2032)
  3. 6.2.1 Global Lisinopril Sales by Region (2021-2026)
  4. 6.2.2 Global Lisinopril Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lisinopril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lisinopril Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lisinopril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lisinopril Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lisinopril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lisinopril Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lisinopril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lisinopril Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lisinopril Revenue by Region
  1. 7.1 Global Lisinopril Revenue by Region
  2. 7.1.1 Global Lisinopril Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lisinopril Revenue by Region (2021-2026)
  4. 7.1.3 Global Lisinopril Revenue by Region (2027-2032)
  5. 7.1.4 Global Lisinopril Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lisinopril Revenue (2021-2032)
  8. 7.2.2 North America Lisinopril Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lisinopril Revenue (2021-2032)
  11. 7.3.2 Europe Lisinopril Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lisinopril Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lisinopril Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lisinopril Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lisinopril Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Lisinopril Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Lisinopril Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Mylan Pharmaceuticals
  14. 8.3.1 Mylan Pharmaceuticals Company Information
  15. 8.3.2 Mylan Pharmaceuticals Business Overview
  16. 8.3.3 Mylan Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Pharmaceuticals Lisinopril Product Portfolio
  18. 8.3.5 Mylan Pharmaceuticals Recent Developments
  19. 8.4 Astrazeneca
  20. 8.4.1 Astrazeneca Company Information
  21. 8.4.2 Astrazeneca Business Overview
  22. 8.4.3 Astrazeneca Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Astrazeneca Lisinopril Product Portfolio
  24. 8.4.5 Astrazeneca Recent Developments
  25. 8.5 Wockhardt
  26. 8.5.1 Wockhardt Company Information
  27. 8.5.2 Wockhardt Business Overview
  28. 8.5.3 Wockhardt Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wockhardt Lisinopril Product Portfolio
  30. 8.5.5 Wockhardt Recent Developments
  31. 8.6 West Ward Pharmaceutical
  32. 8.6.1 West Ward Pharmaceutical Company Information
  33. 8.6.2 West Ward Pharmaceutical Business Overview
  34. 8.6.3 West Ward Pharmaceutical Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 West Ward Pharmaceutical Lisinopril Product Portfolio
  36. 8.6.5 West Ward Pharmaceutical Recent Developments
  37. 8.7 Watson Laboratories
  38. 8.7.1 Watson Laboratories Company Information
  39. 8.7.2 Watson Laboratories Business Overview
  40. 8.7.3 Watson Laboratories Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Watson Laboratories Lisinopril Product Portfolio
  42. 8.7.5 Watson Laboratories Recent Developments
  43. 8.8 Vintage Pharmaceuticals
  44. 8.8.1 Vintage Pharmaceuticals Company Information
  45. 8.8.2 Vintage Pharmaceuticals Business Overview
  46. 8.8.3 Vintage Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vintage Pharmaceuticals Lisinopril Product Portfolio
  48. 8.8.5 Vintage Pharmaceuticals Recent Developments
  49. 8.9 SUN Pharm
  50. 8.9.1 SUN Pharm Company Information
  51. 8.9.2 SUN Pharm Business Overview
  52. 8.9.3 SUN Pharm Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SUN Pharm Lisinopril Product Portfolio
  54. 8.9.5 SUN Pharm Recent Developments
  55. 8.10 Ranbaxy Pharmaceuticals
  56. 8.10.1 Ranbaxy Pharmaceuticals Company Information
  57. 8.10.2 Ranbaxy Pharmaceuticals Business Overview
  58. 8.10.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ranbaxy Pharmaceuticals Lisinopril Product Portfolio
  60. 8.10.5 Ranbaxy Pharmaceuticals Recent Developments
  61. 8.11 Prinston
  62. 8.11.1 Prinston Company Information
  63. 8.11.2 Prinston Business Overview
  64. 8.11.3 Prinston Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Prinston Lisinopril Product Portfolio
  66. 8.11.5 Prinston Recent Developments
  67. 8.12 Merck Research Laboratories
  68. 8.12.1 Merck Research Laboratories Company Information
  69. 8.12.2 Merck Research Laboratories Business Overview
  70. 8.12.3 Merck Research Laboratories Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Research Laboratories Lisinopril Product Portfolio
  72. 8.12.5 Merck Research Laboratories Recent Developments
  73. 8.13 Lupin
  74. 8.13.1 Lupin Company Information
  75. 8.13.2 Lupin Business Overview
  76. 8.13.3 Lupin Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Lupin Lisinopril Product Portfolio
  78. 8.13.5 Lupin Recent Developments
  79. 8.14 Lek Pharmaceuticals
  80. 8.14.1 Lek Pharmaceuticals Company Information
  81. 8.14.2 Lek Pharmaceuticals Business Overview
  82. 8.14.3 Lek Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Lek Pharmaceuticals Lisinopril Product Portfolio
  84. 8.14.5 Lek Pharmaceuticals Recent Developments
  85. 8.15 Ivax Pharmaceuticals
  86. 8.15.1 Ivax Pharmaceuticals Company Information
  87. 8.15.2 Ivax Pharmaceuticals Business Overview
  88. 8.15.3 Ivax Pharmaceuticals Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ivax Pharmaceuticals Lisinopril Product Portfolio
  90. 8.15.5 Ivax Pharmaceuticals Recent Developments
  91. 8.16 Invagen Pharms
  92. 8.16.1 Invagen Pharms Company Information
  93. 8.16.2 Invagen Pharms Business Overview
  94. 8.16.3 Invagen Pharms Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Invagen Pharms Lisinopril Product Portfolio
  96. 8.16.5 Invagen Pharms Recent Developments
  97. 8.17 Hikma
  98. 8.17.1 Hikma Company Information
  99. 8.17.2 Hikma Business Overview
  100. 8.17.3 Hikma Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hikma Lisinopril Product Portfolio
  102. 8.17.5 Hikma Recent Developments
  103. 8.18 CASI Pharms
  104. 8.18.1 CASI Pharms Company Information
  105. 8.18.2 CASI Pharms Business Overview
  106. 8.18.3 CASI Pharms Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CASI Pharms Lisinopril Product Portfolio
  108. 8.18.5 CASI Pharms Recent Developments
  109. 8.19 Aurobindo Pharma
  110. 8.19.1 Aurobindo Pharma Company Information
  111. 8.19.2 Aurobindo Pharma Business Overview
  112. 8.19.3 Aurobindo Pharma Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Aurobindo Pharma Lisinopril Product Portfolio
  114. 8.19.5 Aurobindo Pharma Recent Developments
  115. 8.20 Apotex
  116. 8.20.1 Apotex Company Information
  117. 8.20.2 Apotex Business Overview
  118. 8.20.3 Apotex Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Apotex Lisinopril Product Portfolio
  120. 8.20.5 Apotex Recent Developments
  121. 8.21 Alvogen
  122. 8.21.1 Alvogen Company Information
  123. 8.21.2 Alvogen Business Overview
  124. 8.21.3 Alvogen Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Alvogen Lisinopril Product Portfolio
  126. 8.21.5 Alvogen Recent Developments
  127. 8.22 Actavis Elizabeth
  128. 8.22.1 Actavis Elizabeth Company Information
  129. 8.22.2 Actavis Elizabeth Business Overview
  130. 8.22.3 Actavis Elizabeth Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Actavis Elizabeth Lisinopril Product Portfolio
  132. 8.22.5 Actavis Elizabeth Recent Developments
  133. 8.23 Accord Hlthcare
  134. 8.23.1 Accord Hlthcare Company Information
  135. 8.23.2 Accord Hlthcare Business Overview
  136. 8.23.3 Accord Hlthcare Lisinopril Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Accord Hlthcare Lisinopril Product Portfolio
  138. 8.23.5 Accord Hlthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lisinopril Value Chain Analysis
  2. 9.1.1 Lisinopril Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lisinopril Production Mode & Process
  6. 9.2 Lisinopril Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lisinopril Distributors
  9. 9.2.3 Lisinopril Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst